V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 280006292 | 280003869 | 1.69 | 63.3 | Palliative (P) | 2015-10-02 | 2015-10-06 | Cyclophosphamide oral | 2 | N | 280030628 | DOXORUBICIN + OLARATUMAB |
| 280006293 | 280008111 | 1.8 | 64.6 | Curative (C) | 2016-06-06 | 2016-06-06 | Paclitaxel 7 day | 02 | N | 280030629 | CISPLATIN + FLUOROURACIL + RT |
| 280006294 | 280008111 | 1.89 | 0 | Palliative (P) | 2014-07-22 | 2014-08-08 | Carboplatin+Fluorouracil 4 or 5 day | N | N | 280030629 | PACLITAXEL |
| 280006295 | 280008111 | 1.73 | 70.5 | Curative (C) | 2013-10-17 | 2013-10-23 | DE-ESCALATE TRIAL | N | null | 280030629 | CISPLATIN + FLUOROURACIL + RT |
| 280006296 | 280008111 | 1.76 | null | Neo-adjuvant (N) | 2015-01-30 | 2015-02-07 | Doxorubicin + Olaratumab | 02 | N | 280030629 | TCF |
| 280006297 | 280003870 | 1.67 | 98.75 | Curative (C) | 2013-06-21 | 2013-07-04 | Folfirinox | N | null | 280030635 | CISPLATIN + FLUOROURACIL + RT |
| 280006298 | 280008112 | 1.62 | 105 | Neo-adjuvant (N) | 2016-06-02 | 2016-06-07 | GDP | 02 | N | 280030636 | VIDE |
| 280006299 | 280003871 | 1.76 | 117.4 | Curative (C) | 2017-10-09 | 2017-12-08 | Dactinomycin + Vincristine | N | N | 280030638 | COMPARE TRIAL |
| 280006300 | 280003871 | 1.7 | 65.4 | Palliative (P) | 2015-08-11 | 2015-08-11 | Carboplatin + Pemetrexed | 02 | N | 280030638 | DOXORUBICIN + OLARATUMAB |
| 280006301 | 280003871 | 0.76 | 87 | null | 2016-05-15 | 2016-05-14 | Mitomycin Intravesical | null | null | 280030638 | PACLITAXEL |
| 280006302 | 280003871 | 1.58 | 74.8 | Palliative (P) | 2018-04-09 | 2018-04-18 | CISPLATIN + FLUOROURACIL + RT | 02 | N | 280030638 | DACTINOMYCIN + CYCLO + VINCRISTINE |
| 280006303 | 280003871 | null | 56.1 | Palliative (P) | 2017-08-14 | 2017-08-25 | FEC + DOCETAXEL | 2 | N | 280030638 | PACLITAXEL |
| 280006304 | 280003871 | 1.67 | 122.8 | Neo-adjuvant (N) | null | 2016-11-03 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN | null | null | 280030638 | CISPLATIN + DOCETAXEL |
| 280006305 | 280003871 | 1.71 | 54 | Curative (C) | 2016-08-20 | 2016-08-20 | Mitomycin Intravesical | 2 | Y | 280030638 | IVA |
| 280006306 | 280012055 | 1.55 | 48.8 | Palliative (P) | 2015-10-23 | 2015-10-26 | Capecitabine (21days) + Carboplatin | 02 | N | 280030660 | PACLITAXEL |
| 280006307 | 280003872 | 1.7 | 85.7 | Curative (C) | 2014-03-03 | 2014-03-06 | Carbo F | Y | N | 280030662 | MITOMYCIN INTRAVESICULAR |
| 280006308 | 280003872 | 1.6 | null | null | 2016-04-29 | 2016-05-02 | STS Rhabdo Rel BERNIE IVADo | null | null | 280030662 | PACLITAXEL |
| 280006309 | 280003873 | 1.76 | 83 | Curative (C) | 2016-04-09 | 2016-04-23 | PACLITAXEL | N | N | 280030665 | EURO-EWING |
| 280006310 | 280003874 | 1.8 | 91 | Palliative (P) | 2016-08-21 | 2016-08-29 | FLUOROURACIL + OXALIPLATIN | 02 | null | 280030666 | CETUXIMAB + CISPLATIN + FU |
| 280006311 | 280003874 | null | -1 | Palliative (P) | 2016-04-08 | 2016-04-14 | Paclitaxel 80mg/m2 day 1 8 15 | Y | null | 280030666 | PACLITAXEL |
| 280006312 | 280003874 | 1.63 | 76.6 | Palliative (P) | 2014-06-15 | 2014-06-24 | Carboplatin + Liposomal Doxorubicin | N | N | 280030666 | CYTARABINE |
| 280006313 | 280003874 | 1.55 | 72 | Curative (C) | null | 2014-09-27 | STS Rhabdomyosarcoma RMS 2005 IVA | null | null | 280030666 | IVADO |
| 280006314 | 280003875 | 1.52 | 36 | Adjuvant (A) | 2017-07-24 | 2017-08-08 | Fluorouricil + Folonic Acid (MdG) | N | N | 280030672 | RITUXIMAB |
| 280006315 | 280003876 | 1.6 | 99.6 | Neo-adjuvant (N) | 2015-01-01 | 2015-01-13 | CAPECITABINE + OXALIPLATIN | N | N | 280030673 | EURO-EWING |
| 280006316 | 280003877 | 0 | 95 | Palliative (P) | 2014-07-14 | 2014-07-15 | Oxaliplatin + Modified de Gramont | N | null | 280030674 | DOXORUBICIN + OLARATUMAB |
| 280006317 | 280003877 | 1.66 | 76.6 | Palliative (P) | 2014-10-10 | 2014-10-16 | CARBOPLATIN + GEMCITABINE | 02 | null | 280030674 | DOCETAXEL + GEMCITABINE |
| 280006318 | 280003878 | null | 88.3 | Palliative (P) | 2014-05-13 | 2014-05-21 | DE-ESCALATE TRIAL | N | N | 280030683 | DOXORUBICIN + OLARATUMAB |
| 280006319 | 280003879 | 1.53 | 106 | Palliative (P) | 2016-02-10 | 2016-02-18 | CAPECITABINE + CARBOPLATIN + Cetuximab | 2 | N | 280030684 | CARBOPLATIN + CETUXIMAB + FU |
| 280006320 | 280003879 | 1.79 | 58 | Curative (C) | 2015-07-24 | 2015-08-01 | ECX | 02 | N | 280030684 | CISPLATIN + FLUOROURACIL + RT |
| 280006321 | 280003880 | null | 92 | Curative (C) | 2014-05-27 | 2014-05-27 | Cisplatin + Fluorouracil + RT 5day | N | N | 280030688 | VIDE |
| 280006322 | 280008118 | 1.8 | null | Curative (C) | 2015-09-24 | 2015-09-25 | ECX | N | N | 280030689 | IVA |
| 280006323 | 280003881 | 1.68 | 55.2 | Disease modification (D) | 2016-02-15 | 2016-03-04 | Capecitabine + Oxaliplatin 14day | N | N | 280030690 | CAPECITABINE + TEMOZOLOMIDE |
| 280006324 | 280003882 | 1.8 | null | Palliative (P) | 2013-12-08 | 2013-12-12 | Vinorelbine (oral) | N | null | 280030692 | CARBOPLATIN + CETUXIMAB + FLUOROURACIL |
| 280006325 | 280003882 | 1.58 | 51 | Palliative (P) | 2013-08-18 | 2013-09-04 | VAC | N | N | 280030692 | DOCETAXEL |
| 280006326 | 280010120 | 1.78 | 67.8 | null | 2017-08-12 | 2017-08-20 | GEDDIS TRIAL | N | N | 280030699 | PACLITAXEL |
| 280006327 | 280011120 | 1.6 | 78 | Palliative (P) | 2017-04-06 | 2017-04-06 | BCG Intravesical | N | N | 280030700 | VIDE |
| 280006328 | 280003883 | 1.82 | 71 | Palliative (P) | 2017-10-16 | 2017-11-07 | Oxaliplatin + Modified de Gramont | null | null | 280030701 | PACLITAXEL |
| 280006329 | 280008120 | null | 110.6 | Palliative (P) | 2018-07-16 | 2018-07-23 | MELPHALAN | null | N | 280030702 | CYCLOPHOSPHAMIDE |
| 280006330 | 280003884 | 1.8 | 60 | Adjuvant (A) | 2017-07-18 | 2017-07-18 | TCF | 02 | null | 280030704 | DE-ESCALATE TRIAL |
| 280006331 | 280003885 | 1.7 | 86.3 | null | 2016-06-28 | 2016-11-01 | GemCarbo Days 1+8 | 02 | N | 280030705 | IVA |
| 280006332 | 280003886 | 1.58 | null | Palliative (P) | 2014-03-30 | 2014-05-04 | Carbo F | N | N | 280030706 | PEMBROLIZUMAB |
| 280006333 | 280003886 | 1.7 | 115 | Palliative (P) | 2013-01-09 | 2013-02-05 | CAPECITABINE + OXALIPLATIN | N | N | 280030706 | CARBO + FLUOROURACIL |
| 280006334 | 280003886 | 1.64 | null | Curative (C) | null | 2015-09-07 | Carbo F | null | null | 280030706 | CISPLATIN + FLUOROURACIL + RT |
| 280006335 | 280003886 | 1.7 | null | Palliative (P) | 2018-01-06 | 2018-01-14 | PEMBROLIZUMAB | null | null | 280030706 | IRINOTECAN + MDG |
| 280006336 | 280003887 | null | 82.9 | Palliative (P) | 2016-05-21 | 2016-05-22 | ECX | N | N | 280030711 | DOXORUBICIN + OLARATUMAB |
| 280006337 | 280003887 | null | 82.4 | null | 2015-05-01 | 2015-05-30 | EW EuroEwing 99 : VIDE | N | Y | 280030711 | CARBOPLATIN + PACLITAXEL + RT |
| 280006338 | 280003887 | 1.63 | 59.6 | Palliative (P) | 2017-03-10 | 2017-03-14 | BEP 5 Day | Y | N | 280030711 | CAPECITABINE |
| 280006339 | 280003888 | 1.8 | 71.75 | Curative (C) | 2013-09-05 | 2013-09-24 | Carboplatin+Fluorouracil 4 or 5 day | null | N | 280030715 | DE-ESCALATE TRIAL |
| 280006340 | 280008123 | 1.65 | 60.7 | Neo-adjuvant (N) | 2017-11-15 | 2017-11-15 | VDC | N | N | 280030716 | EURO-EWING |
| 280006341 | 280008123 | 1.68 | 58.9 | Palliative (P) | 2015-02-05 | 2015-02-09 | Fluorouricil + Folonic Acid (MdG) | 02 | N | 280030716 | CAV |